Total medical devices industry venture financing deals in Q4 2019 worth $2.94bn were announced globally, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 25.4% over the previous quarter and a rise of 22.6% when compared with the last four-quarter average, which stood at $2.4bn.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $1.89bn. At the country level, the US topped the list in terms of deal value at $1.87bn.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe top country in terms of venture financing deals activity in Q4 2019 was the US with 169 deals, followed by China with 30 and Canada with 11.
In 2019, as of the end of Q4 2019, medical devices venture financing deals worth $10.57bn were announced globally, marking an increase of 9.5% year on year.
Medical devices industry venture financing deals in Q4 2019: Top deals
The top five medical devices industry venture financing deals accounted for 18.3% of the overall value during Q4 2019.
The combined value of the top five medical devices venture financing deals stood at $538.39m, against the overall value of $2.94bn recorded for the month.
The top five medical devices industry deals of Q4 2019 tracked by GlobalData were:
1) Foresite Capital Management, JS Capital Management, Merieux Developpement, MLS Capital Fund II, NanoDimension Management, Oak HC/FT Partners, Paladin Capital Group and Venrock’s $125m venture financing of Inscripta
2) The $114.39m venture financing of Geneseeq Technology by China ReformLtd, Lilly Asia ventures and Softbank China Venture Capital
3) Battery Ventures, Bessemer Venture Partners, Claltech, Israel Cleantech Ventures, ITI Venture Capital, Koch Disruptive Technologies and Walden Riverwood Ventures’ $109m venture financing of Vayyar Imaging
4) The $100m venture financing of Peijia Medical by China Chengtong Holdings Group, Grand Flight Investment Management, Lilly Asia ventures, Matrix Partners China and SDIC Fund Management
5) Foresite Capital Management’s venture financing of GenapSys for $90m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
